Treatment of cognitive impairment in patients with multiple sclerosis

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.21, Iss.11, 2012-11, pp. : 1679-1699

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment of Cognitive Impairment in Multiple Sclerosis: Is the Use of Acetylcholinesterase Inhibitors a Viable Option?

By Christodoulou Christopher

CNS Drugs, Vol. 22, Iss. 2, 2008-01 ,pp. : 87-97

Adis International

Access to resources Recommend Favorite

Treatment of walking impairment in multiple sclerosis: an unmet need for a disease-specific disability

By Panitch Hillel Applebee Angela

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 10, 2011-07 ,pp. : 1511-1521

Informa Healthcare

Access to resources Recommend Favorite

Stress, Depression and Antidepressant Treatment Options in Patients Suffering from Multiple Sclerosis

Current Pharmaceutical Design, Vol. 18, Iss. 36, 2012-12 ,pp. : 5837-5845

Bentham Science Publishers

Access to resources Recommend Favorite

Multiple sclerosis and its treatment

By Giovannoni Gavin Miller David H

Clinical Medicine, Vol. 33, Iss. 4, 1999-07 ,pp. : 315-322

Royal College Of Physicians

Access to resources Recommend Favorite

Multiple Sclerosis: Pathogenesis and Treatment

Current Neuropharmacology, Vol. 9, Iss. 3, 2011-09 ,pp. : 409-416

Bentham Science Publishers

Access to resources Recommend Favorite